Krebs Biochemicals & Industries (KREBSBIO) Share Price falls 8.39% as Micro Cap stock trades lower
- October 5, 2026
- Posted by: Kunal Singla
- Category: News
Krebs Biochemicals Share Price is in focus after Krebs Biochemicals & Industries traded at Rs 63.58, down 8.39% from the previous close of Rs 69.40. The stock’s market capitalisation stood at Rs 149.63 crore, placing it in the Micro Cap category. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers tracking Krebs Biochemicals Share Price Today, the move matters because it brings the stock’s valuation, profitability profile and healthcare sector context into sharper view. As of 05 October 2026 at 11:22:52 AM IST, Krebs Biochemicals Share Price and Krebs Biochemicals Stock News are being watched for what the numbers show rather than for any unverified trigger.
In Krebs Biochemicals Share Price terms, the intraday range was tight but clearly weaker: the stock opened at Rs 66.75, touched a high of Rs 67.10 and a low of Rs 62.60. The day change of Rs -5.82 shows the extent of the move in a single trading update. This Krebs Biochemicals Share Price Today action keeps investors focused on whether the latest decline is only a price event or also part of a broader valuation re-rating relative to the company’s own operating metrics. Univest data allows the comparison to stay factual and tied to the actual numbers.
Krebs Biochemicals & Industries (KREBSBIO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 63.58 |
| Previous Close | Rs 69.4 |
| Today's Move | -Rs 5.82 (-8.39%) |
| Open | Rs 66.75 |
| High | Rs 67.1 |
| Low | Rs 62.6 |
| Market Capitalisation | Rs 149.63 crore |
| Market Cap Category | Micro Cap |
Krebs Biochemicals Share Price Today reflects a decline from Rs 69.40 to Rs 63.58, a fall of 8.39% in the latest trade. The stock opened below the previous close at Rs 66.75, moved up to Rs 67.10, and then slipped to a low of Rs 62.60 before last trading at Rs 63.58. That range shows where the stock was transacting during the market update, without implying a reason that is not verified. With a market capitalisation of Rs 149.63 crore, Krebs Biochemicals remains a Micro Cap company. For Krebs Biochemicals Share Price watchers, the current move is best read as a sharp one-day price event that now feeds directly into Krebs Biochemicals Share Price News and Krebs Biochemicals Stock Analysis.
What matters next is how the market treats Krebs Biochemicals Share Price around this level in relation to its fundamentals and sector peers. The current trade is below both the opening level and the prior close, while the low of Rs 62.60 shows how far the stock was pressed within the trading window. Univest data confirms the decline, but it does not establish a company-specific catalyst. That makes the next section on Krebs Biochemicals Share Price and fundamentals especially relevant.
Krebs Biochemicals & Industries (KREBSBIO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 149.63 crore |
| P/B Ratio | -0.91x |
| ROCE | -15.38% |
| EPS | Rs -6.54 |
| Book Value Per Share | Rs -76.64 |
| Dividend Yield | 0% |
Krebs Biochemicals & Industries (KREBSBIO) fundamental metrics show P/B -0.91x, ROCE -15.38%. Taken on their own, these numbers offer context rather than a trading signal.
Krebs Biochemicals & Industries has a market capitalisation of Rs 149.63 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at -0.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROCE of -15.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -6.54, book value per share of Rs -76.64, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.27x, median ROE of 11.48%, median ROCE of 13.17%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.27x |
| Benchmark Average P/E | 48.67x |
| Benchmark P/E Range | 3.58x to 685.2x |
| Company P/B Ratio | -0.91x |
| Benchmark Median P/B | 2.87x |
| Benchmark Average P/B | 4.28x |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10% |
| Company ROCE | -15.38% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.77% |
| Company Market Capitalisation | Rs 149.63 crore |
| Benchmark Median Market Cap | Rs 714 crore |
| Benchmark Average Market Cap | Rs 13,708.65 crore |
Krebs Biochemicals & Industries (KREBSBIO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Krebs Biochemicals & Industries (KREBSBIO) has a ROCE of -15.38%, which is below the benchmark median of 13.17%, a difference of -216.78%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,34,279.63 | 35.9 | 5.02 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,737.12 | 84.35 | 13.97 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,129.27 | 83.05 | 20.18 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,14,239.13 | 25.31 | 4.24 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,08,808.05 | 32.28 | 3.1 | 11.83 | 16 |
ROCE stood at -15.38% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Krebs Biochemicals & Industries (KREBSBIO) has a market capitalisation of Rs 149.63 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Krebs Biochemicals
- Krebs Biochemicals Share Price fell 8.39% in the latest trade, making the move visible in today’s market screen.
- The stock traded between Rs 62.60 and Rs 67.10, giving a clear intraday range for Krebs Biochemicals Share Price Today.
- Market capitalisation of Rs 149.63 crore places Krebs Biochemicals in the Micro Cap category.
- Negative P/B, EPS and ROCE keep Krebs Biochemicals Fundamental Analysis in focus.
- The healthcare and pharmaceuticals peer set provides a useful valuation and return benchmark for Krebs Biochemicals Share Price.
About Krebs Biochemicals & Industries
Krebs Biochemicals & Industries operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by investors as a listed Micro Cap name with a market capitalisation of Rs 149.63 crore. For Krebs Biochemicals Share Price readers, the main business context comes from its sector placement and its comparison with other pharmaceutical companies rather than from a large-scale market position. The latest Univest figures show the stock as part of a wider healthcare universe where return ratios, book value and peer valuation often shape how Share Price moves are interpreted.
In practical terms, Krebs Biochemicals Share Price reflects how the market values a small listed healthcare company with weak profitability markers. That makes the stock relevant for investors who follow company overview, stock performance and sector analysis in the same place.
Track Krebs Biochemicals Share Price on Univest
Use Krebs Biochemicals & Industries (KREBSBIO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Krebs Biochemicals Share Price can be tracked on Univest for live price updates, fundamental ratios, 52-week levels and market insights. Readers looking for Krebs Biochemicals Share Price Today can use Univest to follow the stock alongside sector context, valuation metrics and company news in one place. It also helps keep Krebs Biochemicals Stock News and Krebs Biochemicals Stock Analysis connected to the latest listed-company data.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Krebs Biochemicals Share Price fall today?
Ans. Krebs Biochemicals Share Price fell 8.39% to Rs 63.58 in the latest trade. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as verified price action.
What is Krebs Biochemicals Share Price today?
Ans. Krebs Biochemicals Share Price today is Rs 63.58, compared with the previous close of Rs 69.40. The stock moved lower by Rs 5.82 in the latest trade and remained within an intraday range of Rs 62.60 to Rs 67.10.
What is the market capitalisation of Krebs Biochemicals?
Ans. Krebs Biochemicals has a market capitalisation of Rs 149.63 crore. That places it in the Micro Cap category and well below the same-industry market cap median of Rs 714 crore across the benchmark set.
How does Krebs Biochemicals compare with healthcare peers?
Ans. Krebs Biochemicals Share Price sits beside peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharma and Zydus Lifesciences. Its negative P/B and negative ROCE differ sharply from the positive return and valuation profiles of those listed companies.
What do Krebs Biochemicals EPS and book value show?
Ans. Krebs Biochemicals reports EPS of Rs -6.54 and book value of Rs -76.64. Those figures indicate a weak accounting profile in the latest reading and help explain why Krebs Biochemicals Share Price is being watched closely.
What does the P/B ratio mean for Krebs Biochemicals Share Price?
Ans. The P/B ratio is -0.91, which is below the same-industry median of 2.87. For Krebs Biochemicals Share Price, that reflects a valuation structure that differs materially from many healthcare peers in the benchmark group.
How does Krebs Biochemicals ROCE compare with the sector?
Ans. Krebs Biochemicals has ROCE of -15.38%, while the same-industry benchmark median is 13.17% and average is 12.77%. That gap shows the stock is operating with a much weaker return profile than the sector reference set.
Should investors track Krebs Biochemicals Share Price on Univest?
Ans. Yes, investors tracking Krebs Biochemicals Share Price can use Univest for live price updates, fundamental ratios, 52-week levels and market insights. The platform keeps the stock’s price action and valuation context in one place for regular monitoring.
